A detailed history of Assetmark, Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Assetmark, Inc holds 100 shares of TECH stock, worth $7,872. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Holding current value
$7,872
% of portfolio
0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$62.12 - $84.15 $6,212 - $8,415
100 New
100 $7,000
Q4 2023

Feb 09, 2024

BUY
$52.83 - $78.22 $528 - $782
10 New
10 $0
Q1 2022

May 13, 2022

SELL
$353.85 - $487.79 $707 - $975
-2 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$444.87 - $538.88 $889 - $1,077
2 New
2 $1,000
Q2 2021

Aug 16, 2021

SELL
$387.35 - $450.26 $774 - $900
-2 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$314.62 - $411.0 $629 - $822
2 New
2 $1,000
Q1 2018

May 16, 2018

SELL
$131.46 - $151.04 $920 - $1,057
-7 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$121.17 - $134.75 $605 - $673
5 Added 250.0%
7 $1,000
Q4 2016

Sep 15, 2017

BUY
N/A
2
2 $0

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $3.09B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.